{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:06:25Z","timestamp":1790730385303,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jsat.2021.108279","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:25:07Z","timestamp":1610475907000},"page":"108279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A systematic review of integrative medicine for opioid withdrawal"],"prefix":"10.1016","volume":"125","author":[{"given":"Caroline","family":"Kruszecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney R.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jsat.2021.108279_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2710.2001.00366.x","article-title":"Passionflower in the treatment of opiates withdrawal: A double-blind randomized controlled trial","volume":"26","author":"Akhondzadeh","year":"2001","journal-title":"Journal of Clinical Pharmacy and Therepeutics"},{"key":"10.1016\/j.jsat.2021.108279_bb0010","unstructured":"American Addiction Centers. (n.d.). Opiate Withdrawal Timelines, Symptoms and Treatment. Available at: https:\/\/americanaddictioncenters.org\/withdrawal-timelines-treatments\/opiate. Accessed March 9, 2020."},{"key":"10.1016\/j.jsat.2021.108279_bb0015","unstructured":"American Society of Addiction Medicine. (n.d.). The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opiate Use. Available at: https:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guideline-supplement.pdf. Accessed March 9, 2020."},{"key":"10.1016\/j.jsat.2021.108279_bb0020","unstructured":"Centers for Disease Control and Prevention. (n.d.). U.S. Opioid Prescribing Maps. Available at: https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate-maps.html. Accessed March 8, 2020."},{"issue":"3","key":"10.1016\/j.jsat.2021.108279_bb0025","first-page":"205","article-title":"Traditional Chinese and Indian medicine in the treatment of opioid-dependence: A review","volume":"3","author":"Doosti","year":"2013","journal-title":"Avicenna Journal of Phytomedicine"},{"key":"10.1016\/j.jsat.2021.108279_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"issue":"3","key":"10.1016\/j.jsat.2021.108279_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/02791072.2000.10400450","article-title":"Comparative clinical study of the effect of WeiniCom, a Chinese herbal compound, on alleviation of withdrawal symptoms and craving for heroin in detoxification treatment","volume":"32","author":"Hao","year":"2000","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2021.108279_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1016\/j.jsat.2021.108279_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/00952990802013409","article-title":"Tai-Kang-Ning, a Chinese herbal medicine formula, alleviates acute heroin withdrawal","volume":"34","author":"Kang","year":"2008","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2021.108279_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2021.108279_bb0055","unstructured":"Lei G. (2007). Controlled study of detoxificated effect of Fuyuan pellet and lofexidine hydrochloride on opiate withdrawal symptoms. Master paper, 1\u201322."},{"key":"10.1016\/j.jsat.2021.108279_bb0060","series-title":"Withdrawal syndrome rating scale","author":"Ministry of the Health of the People\u2019\u2019s Republic of China","year":"1994"},{"issue":"1","key":"10.1016\/j.jsat.2021.108279_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12911-019-0834-8","article-title":"The past, present and future of opioid withdrawal assessment: A scoping review of scales and technologies","volume":"19","author":"Nuamah","year":"2019","journal-title":"BMC Medical Informatics and Decision Making"},{"issue":"6","key":"10.1016\/j.jsat.2021.108279_bb0070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/00952990802491563","article-title":"A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms","volume":"34","author":"Shi","year":"2008","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1016\/j.jsat.2021.108279_bb0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/00952990903377146","article-title":"A study on Fu-Yuan pellet, a traditional Chinese medicine formula for detoxification of heroin addictions","volume":"35","author":"Wang","year":"2009","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2021.108279_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(82)90509-X","article-title":"Suppression of withdrawal symptoms by dynorphin in heroin addicts","volume":"82","author":"Wen","year":"1982","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jsat.2021.108279_bb0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1745-7254.2008.00817.x","article-title":"Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: A pilot study","volume":"29","author":"Yang","year":"2008","journal-title":"Acta Pharmacologica Sinica"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:06Z","timestamp":1760039586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":17,"alternative-id":["S0740547221000052"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108279","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of integrative medicine for opioid withdrawal","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108279"}}